Announcements Trials

Browse Landscape

Status

Recruiting 5797 Active not recruiting 2952 Completed 1685 Not yet recruiting 1596 Terminated 371 Enrolling by invitation 177 Suspended 128 Withdrawn 102 Available 27 No longer available 4 Approved for marketing 2 Temporarily not available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

telisotuzumab vedotin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Temporarily not available × 90 days × Clear all

NCT04830202 2026-05-13

Expanded Access to Telisotuzumab Vedotin

AbbVie

Temporarily not available

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡